Did you mean: concern
Showing 1-1 of 1 results
-
Gilead to pay $11.9bn for cancer treatment developer Kite
Associated Press, Published on 28/08/2017
ยป Gilead Sciences will pay $11.9 billion in cash to buy Kite Pharma and plant a stake in an emerging area of cancer treatments that train a patient's immune cells to attack tumours.
Your recent history
-
Recently searched
-
Recently viewed links